Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Gropro Corporation has three pending office actions in Biotechnology & Pharmaceuticals. The matters involve two examiners and two art units, showing some distribution across examination channels while retaining a smaller assignment structure than the number of pending actions. EVANS, JASMINE AFIYA is the busiest examiner, with two pending matters.
The examiner concentration makes consistency with EVANS, JASMINE AFIYA particularly relevant to portfolio management. Counsel should still account for the other examiner and art-unit assignment, because not all pending activity follows the same path. A practical strategy is to coordinate shared technical positions while tailoring responses to the separate examination relationships.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EVANS, JASMINE AFIYA | 2 | 100.0% | +0.0% |
| KIM, DANIELLE A | 1 | 36.6% | +51.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18484648 | CHITOSAN ENCAPSULATION OF OXYMATRINE AND TEA SAPONIN FOR USE IN PESTICIDAL ACTIVITY | EVANS, JASMINE AFIYA | 126d overdue |
| 18484603 | CHITOSAN ENCAPSULATION OF GERANIOL FOR USE IN PESTICIDAL ACTIVITY | EVANS, JASMINE AFIYA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18433393 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | KIM, DANIELLE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18433393 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 1616 | 2 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18433393 | CHITOSAN ENCAPSULATION OF ABSOLUTE (ESSENTIAL) ROSEMARY, PEPPERMINT, AND COTTONSEED OILS | KIM, DANIELLE A | 1613 | §103§112Other | Final Rejection | — | Pending | Feb 05, 2024 |
| 18484603 | CHITOSAN ENCAPSULATION OF GERANIOL FOR USE IN PESTICIDAL ACTIVITY | EVANS, JASMINE AFIYA | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18484648 | CHITOSAN ENCAPSULATION OF OXYMATRINE AND TEA SAPONIN FOR USE IN PESTICIDAL ACTIVITY | EVANS, JASMINE AFIYA | 1616 | §102§103§112DP | Non-Final OA | 126d overdue | Pending | Oct 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGropro Corporation has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jasmine Afiya Evans has the most, with 2 of Gropro Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
